Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Total Assets: R$6,040 Mil (As of Mar. 2026)


BSP:PFRM3 Profarma Distribuidora De Produtos Farmaceuticos SA BSP:PFRM3
75 GF Score
Price R$6.73
GF Value R$8.04
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Profarma Distribuidora De Produtos Farmaceuticos Total Assets?

Profarma Distribuidora De Produtos Farmaceuticos BSP:PFRM3 -1.03% 75 Total Assets is R$6,040 Mil as of Mar. 2026. GuruFocus rates BSP:PFRM3 with a GF Score™ of 75/100 and a GF Value™ of R$8.04 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Profarma Distribuidora De Produtos Farmaceuticos's Total Assets for the quarter that ended in Mar. 2026 was R$6,040 Mil.

During the past 12 months, Profarma Distribuidora De Produtos Farmaceuticos's average Total Assets Growth Rate was 3.60% per year. During the past 3 years, the average Total Assets Growth Rate was 12.80% per year. During the past 5 years, the average Total Assets Growth Rate was 12.10% per year. During the past 10 years, the average Total Assets Growth Rate was 11.30% per year.

During the past 13 years, Profarma Distribuidora De Produtos Farmaceuticos's highest 3-Year average Total Assets Growth Rate was 27.40%. The lowest was 5.60%. And the median was 12.10%.

Total Assets is connected with ROA %. Profarma Distribuidora De Produtos Farmaceuticos's annualized ROA % for the quarter that ended in Mar. 2026 was -0.11%. Total Assets is also linked to Revenue through Asset Turnover. Profarma Distribuidora De Produtos Farmaceuticos's Asset Turnover for the quarter that ended in Mar. 2026 was 0.47.


Profarma Distribuidora De Produtos Farmaceuticos  (BSP:PFRM3) Total Assets Explanation

Total Assets is connected with ROA %.

Profarma Distribuidora De Produtos Farmaceuticos's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-7/( (6234.275+6039.789)/ 2 )
=-7/6137.032
=-0.11 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Profarma Distribuidora De Produtos Farmaceuticos's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=2873.9/( (6234.275+6039.789)/ 2 )
=2873.9/6137.032
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Profarma Distribuidora De Produtos Farmaceuticos Total Assets Related Terms


Profarma Distribuidora De Produtos Farmaceuticos Total Assets Historical Data

* Premium members only.

The historical data trend for Profarma Distribuidora De Produtos Farmaceuticos's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profarma Distribuidora De Produtos Farmaceuticos Total Assets Chart

Profarma Distribuidora De Produtos Farmaceuticos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,032.89 4,364.93 4,937.93 5,616.24 6,234.28

Profarma Distribuidora De Produtos Farmaceuticos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,788.15 5,370.61 5,636.17 6,234.28 6,039.79
BSP:PFRM3
75GF Score
Profarma Distribuidora De Produtos Farmaceuticos SA BSP:PFRM3
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profarma Distribuidora De Produtos Farmaceuticos Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Profarma Distribuidora De Produtos Farmaceuticos's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=1635.564+4598.711
=6,234

Profarma Distribuidora De Produtos Farmaceuticos's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=1631.703+4408.086
=6,040

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of R$6,040 Mil mean?
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a Total Assets of R$6,040 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors.
Is Profarma Distribuidora De Produtos Farmaceuticos' Total Assets too high?
Profarma Distribuidora De Produtos Farmaceuticos' current Total Assets is R$6,040 Mil. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' Total Assets compare to MCK and CAH?
Profarma Distribuidora De Produtos Farmaceuticos' Total Assets of R$6,040 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Distribution company?
A good Total Assets depends on the Medical Distribution industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. Profarma Distribuidora De Produtos Farmaceuticos's current Total Assets is R$6,040 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.04, compared to a current price of R$6.73 — trading 16.3% below its estimated fair value. The current Total Assets is R$6,040 Mil. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current Total Assets is R$6,040 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?

Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued. The current stock price of R$6.73 is trading 16.3% below its estimated GF Value™ of R$8.04. GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Modestly Undervalued.

Key valuation signals for BSP:PFRM3:

  • Total Assets: R$6,040 Mil
  • GF Value™: R$8.04 vs. price of R$6.73 (16.3% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Profarma Distribuidora De Produtos Farmaceuticos Business Description

Address Avenida Ayrton Senna, 2.150, Bloco P, 3rd floor andar, Barra da Tijuca, RJ, BRA, 22775-900
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
75GF Score

Get the complete analysis for BSP:PFRM3

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.73
Price
R$8.04
GF Value